Study of integrative care for large-cell lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial is looking at an approach to treat large-cell lung cancer. It may help people who have not yet had cancer chemotherapy and who are well enough to do day-to-day activities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years old or younger
- You have been diagnosed with large-cell lung cancer on pathology (a tissue/bopsy test)
- Your overall health allows normal daily activities (WHO performance status 0 or 1)
- You do not have severe problems with major organs (like heart, liver, or kidneys)
- You have not had any prior cancer chemotherapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This study helps doctors improve how they follow lung cancer treatment guidelines. If you join, your care and outcomes will be tracked to see if following guidelines leads to better results.
This trial tests combining chemotherapy, radiation therapy, and two immune-boosting drugs (iparomlimab and tuvonralimab) as a first treatment for locally advanced non-small cell lung cancer that cannot be surgically removed. It aims to see if this combination improves outcomes compared to standard care.
This trial compares two approaches after initial chemotherapy and immunotherapy for advanced non-small cell lung cancer: giving additional local treatment (like surgery or radiation) to remaining spots versus continuing immunotherapy. It aims to see which strategy better controls the cancer.
This study tests a combination of chemotherapy and immunotherapy in people with advanced non-small cell lung cancer that has spread or cannot be removed with surgery. The goal is to see how well this treatment works in patients with different levels of daily activity.
This trial tests a combination of drugs as a maintenance therapy after initial chemotherapy for extensive-stage small cell lung cancer. It aims to see if this combination can help keep the cancer from growing.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.